Mecamylamine Treatment for Alcohol Dependence: A Randomized Controlled Trial

BACKGROUND AND AIMS: The nicotinic acetylcholine receptor antagonist, mecamylamine, is a potential novel pharmacotherapy for alcohol use disorder. The aims were to compare alcohol consumption between mecamylamine and placebo and test if smoking status modified treatment effects. DESIGN: Outpatient,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Addiction
Main Authors: Petrakis, Ismene L., Ralevski, Elizabeth, Gueorguieva, Ralitza, O’Malley, Stephanie S., Arias, Albert, Sevarino, Kevin A., Jane, Jane S., O’Brien, Erin, Krystal, John H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725262/
https://ncbi.nlm.nih.gov/pubmed/28710873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.13943
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados